Immediate Impact
3 from Science/Nature 65 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
Works of Robert Goodloe being referenced
Comparative effectiveness of second-line treatment for non-small cell lung cancer (NSCLC) among patients ≥ 70 versus < 70 years of age.
2015
Rare Variant APOC3 R19X Is Associated With Cardio-Protective Profiles in a Diverse Population-Based Survey as Part of the Epidemiologic Architecture for Genes Linked to Environment Study
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert Goodloe | 233 | 178 | 64 | 122 | 41 | 664 | |
| Kengo Takahashi | 81 | 194 | 33 | 88 | 49 | 584 | |
| Sara Franchi | 100 | 199 | 96 | 95 | 31 | 703 | |
| Elva Pérez‐Luque | 199 | 178 | 21 | 98 | 32 | 813 | |
| Saija Koskimies | 219 | 142 | 23 | 60 | 37 | 838 | |
| M Lunetta | 147 | 96 | 24 | 112 | 48 | 761 | |
| Asako Itaya‐Hironaka | 147 | 168 | 58 | 313 | 38 | 728 | |
| Ye An Kim | 91 | 154 | 28 | 98 | 39 | 639 | |
| Sumiyo Sakuramoto‐Tsuchida | 141 | 133 | 58 | 308 | 35 | 682 | |
| Yoon Hi Cho | 241 | 121 | 26 | 118 | 34 | 760 | |
| Jon H. Levine | 56 | 257 | 47 | 62 | 30 | 798 |
All Works
Loading papers...